new glp-1 drugs The Revolution: From Diabetes and Obesity to Alzheimer's and PCOS GLP-1 Drug Pipeline 2026 |
Description
Additionally, it modifies chemokines, impacting immune cell migration and inflammation
1.5%, respectively)
Canada Latin America Brazil Argentina Mexico Rest of Latin America Europe Germany U.K
Examples include semaglutide (brand names Ozempic and Wegovy), tirzepatide (brand name Mounjaro), and liraglutide (brand names Victoza and Saxenda)
and it can achieve the role of diet control [256], [257], [258]
